Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on July 1, 2019. The company is incorporated in North Carolina and trades on the NYSE American under the symbol YCBD. The filing primarily addresses significant changes to the company's executive leadership structure.
Key Financial Metrics
This filing does not contain financial performance data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing reports the following material changes to corporate governance and executive roles effective July 1, 2019:
- Appointment of Co-CEO: Mr. R. Scott Coffman was appointed as co-Chief Executive Officer.
- Appointment of President: Ms. Caryn Dunayer was appointed as President.
- Role Transition: Mr. Martin A. Sumichrast, previously the sole CEO and Chairman, will continue as Chairman and serve as co-Chief Executive Officer alongside Mr. Coffman.
- Subsidiary Roles: Both Mr. Coffman and Ms. Dunayer will maintain their existing offices and responsibilities with CBD Industries LLC, a wholly owned subsidiary.
Guidance, Outlook, and Management Commentary
The filing includes biographical details for the new appointees but offers no financial guidance, market outlook, or discussion of risks and contingencies.
- Mr. Coffman: A founder of Cure Based Development LLC (merged with cbdMD in Dec 2018) and a Board member. He has served as CEO of CBD Industries LLC since the merger.
- Ms. Dunayer: Previously President of Cure Based Development LLC and CBD Industries LLC. She brings over 15 years of experience in sales, marketing, and digital industries, with prior roles at Hewlett Packard, the Star News, Hearst Corporation, and as co-founder of American Ecig Supply.
- Compensation: Both executives will be compensated according to Executive Employment Agreements entered into on December 20, 2018.
Investor Verification Checklist
- Verify the specific terms of the Executive Employment Agreements (Exhibits 10.4 and 10.5) filed on December 20, 2018, to understand compensation structures.
- Review the definitive Proxy Statement on Schedule 14A (filed March 21, 2019) for full biographical details on Mr. Coffman.
- Confirm the operational impact of the dual CEO structure on strategic decision-making.
- Note that the press release regarding these appointments (Exhibit 99.1) is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.